[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 3809 Introduced in Senate (IS)]

<DOC>






117th CONGRESS
  2d Session
                                S. 3809

 To require the Comptroller General of the United States to conduct a 
 study relating to COVID-19 immunity resulting from a prior infection, 
            vaccination, or both, and the COVID-19 pandemic.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

               March 10 (legislative day, March 7), 2022

Mr. Braun (for himself and Mr. Marshall) introduced the following bill; 
     which was read twice and referred to the Committee on Health, 
                     Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
 To require the Comptroller General of the United States to conduct a 
 study relating to COVID-19 immunity resulting from a prior infection, 
            vaccination, or both, and the COVID-19 pandemic.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Apply the Science Act''.

SEC. 2. GAO STUDY ON NATURAL IMMUNITY IN RELATION TO THE COVID-19 
              PANDEMIC.

    (a) Study.--Not later than 180 days after the date of enactment of 
this Act, the Comptroller General of the United States shall conduct a 
study to determine the following:
            (1) What is the current scientific understanding of the 
        duration and effectiveness of COVID-19 immunity resulting from 
        a prior infection, vaccination, or both, including any 
        differences across population groups.
            (2) To what extent does the Centers for Disease Control and 
        Prevention make available, to key stakeholders, the body of 
        work it has assessed to inform its policy decisions related to 
        COVID-19 infection-acquired and vaccine-induced immunity.
            (3) To what extent do select foreign countries take into 
        account the scientific evidence pertaining to COVID-19 
        infection-acquired immunity when creating public health 
        regulations or guidance.
            (4) To what extent can diagnostic tests that measure the 
        immune response be better utilized in a comprehensive COVID-19 
        response, including in high-risk population groups, and 
        barriers to current use of these diagnostic tests.
    (b) Report.--Not later than 18 months after the date of enactment 
of this Act, the Comptroller General of the United States shall submit 
to the appropriate committees of Congress a report on the 
determinations made pursuant to subsection (a).
                                 <all>